The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis
暂无分享,去创建一个
M. Manns | H. Wedemeyer | C. Falk | I. Prinz | E. Jaeckel | M. Hardtke-Wolenski | C. Koenecke | J. Schlué | J. Dywicki | L. E. Buitrago-Molina | F. Noyan | A. Davalos-Misslitz | K. Hupa-Breier | Maren Lieber | M. Hapke | Solaiman Raha | M. Lieber | M. Hardtke‐Wolenski | L. E. Buitrago‐Molina | Janine Dywicki
[1] M. Manns,et al. Splenectomy Prior to Experimental Induction of Autoimmune Hepatitis Promotes More Severe Hepatic Inflammation, Production of IL-17 and Apoptosis , 2021, Biomedicines.
[2] M. Manns,et al. Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis. , 2020, Journal of autoimmunity.
[3] T. Rassaf,et al. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes , 2020, International journal of molecular sciences.
[4] M. Manns,et al. Absence of Atg7 in the liver disturbed hepatic regeneration after liver injury , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[5] M. Manns,et al. Autoimmune hepatitis induction can occur in the liver , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[6] E. Albano,et al. Adaptive immunity: an emerging player in the progression of NAFLD , 2019, Nature Reviews Gastroenterology & Hepatology.
[7] Caroline L. Wilson,et al. Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer , 2019, Nature Medicine.
[8] Z. Goodman,et al. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis , 2018, Medicine.
[9] T. Chavakis,et al. Innate immune cells in the adipose tissue , 2018, Reviews in Endocrine and Metabolic Disorders.
[10] K. Moore,et al. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression , 2017, The Journal of clinical investigation.
[11] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[12] Ya Cao,et al. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. , 2016, Gastroenterology.
[13] F. Tacke,et al. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies , 2016, Cellular and Molecular Immunology.
[14] Ji Luo,et al. NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis , 2016, Nature.
[15] H. Hermanns,et al. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver , 2016, The Journal of Immunology.
[16] S. Friedman,et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. , 2015, Gastroenterology.
[17] Mark S. Anderson,et al. Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigens , 2015, Hepatology.
[18] Xingchun Wang,et al. Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease. , 2015, International journal of clinical and experimental medicine.
[19] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.
[20] M. Manns,et al. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. , 2014, Journal of hepatology.
[21] H. Moch,et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. , 2014, Cancer cell.
[22] M. Yeh,et al. Strain dependence of diet‐induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[23] J. Stenvang,et al. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.
[24] K. Irvine,et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease , 2014, Hepatology.
[25] Rohit Kohli,et al. IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice , 2014, Hepatology.
[26] G. Targher,et al. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.
[27] M. Manns,et al. Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells , 2013, Hepatology.
[28] M. Manns,et al. Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] Virginia Nguyen,et al. Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production* , 2012, The Journal of Biological Chemistry.
[30] A. Quaas,et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. , 2012, Journal of hepatology.
[31] E. Assier,et al. Interleukin-23: A key cytokine in inflammatory diseases , 2011, Annals of medicine.
[32] L. Chatenoud. Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies? , 2010, Nature Reviews Endocrinology.
[33] E. Jackvony,et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis , 2010, Hepatology.
[34] Christophe Benoist,et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.
[35] J. Zieleński,et al. Normalization of Obesity-Associated Insulin Resistance through Immunotherapy: CD4+ T Cells Control Glucose Homeostasis , 2009, Nature Medicine.
[36] R. Green,et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet , 2008 .
[37] K. Lindor,et al. Nonalcoholic fatty liver disease. , 2007, Annals of epidemiology.
[38] R. Ravi,et al. A high‐fat diet and regulatory T cells influence susceptibility to endotoxin‐induced liver injury , 2007, Hepatology.
[39] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[40] L. Henry,et al. NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .
[41] R. Green,et al. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. , 2004, Journal of hepatology.